Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Permanent Conduction System Pacing vs Native Conduction in Wide QRS with Intermittent Bradycardia

Official title: Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

Run by Spanish Society of Cardiology · NCT07585799 · Data updated 2026-11-12

This study tests whether conduction system pacing can better preserve heart function than native conduction in adults with wide QRS and intermittent bradycardia who need a pacemaker.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorSpanish Society of Cardiology
Academic / other
Locations3 sites (Granada, Andalusia and 2 other locations)
StatusRecruiting
StartedJuly 29, 2025
Main results expectedJanuary 15, 2028
Study endsJanuary 15, 2029
Registry record updatedMay 15, 2026
Trial IDNCT07585799 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with bradycardia requiring a pacemaker, wide QRS (≥150 ms or ≥130 ms with long PR), predominantly intact AV conduction, and LVEF ≥50%.

Probably not a fit

Patients with significant LV dysfunction, persistent AV conduction issues, or conditions making CSP unsuitable may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The multicenter trial is randomized and cross-over, enrolling adults with a pacemaker indication, wide QRS, and predominantly intact AV conduction. It compares conduction system pacing vs native conduction over 12 months, focusing on left ventricular ejection fraction and strain to measure remodeling and dyssynchrony. Primary outcome is the proportion with a ≥10% drop in LVEF or ≥15% drop in GLS at 12 months. Secondary outcomes include functional status, exercise capacity, quality of life, hospitalizations, mortality, arrhythmias, device longevity, and safety. The study uses CSP modalities (LBBP and LVSP) and analyzes subgroups by pacing indication and final CSP modality.

Why it matters

Potential benefit: If CSP shows superior preservation of heart function, patients could experience better overall cardiac performance and quality of life.

How similar studies have gone: Previous work suggests physiologic pacing can improve synchronization, but results vary by modality and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age \> 18 years
* Any indication for cardiac pacing with an expected VP burden ≤ 10% after 1- month run-in period
* Baseline wide QRS (≥150 ms) with normal PR or QRS ≥ 130 ms + PR≥230 ms
* LVEF≥50%
* Confirmed CSP criteria
* Signed and dated informed consent

Exclusion Criteria:

* Pregnant woman
* Permanent or long-lasting atrial fibrillation
* Previous PM/ICD
* Unstable angina, acute Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG), Percutaneous Coronary Angioplasty (PCI), surgical valve repair or replacement within 90 days prior enrollment
* Moderate-severe valvular heart disease (unrepaired)
* Already included in another clinical study that could confound the results of the present study
* Infiltrative disease or any other genetically or acquired primary myocardial disease
* Life expectancy \< 2 years
* LVEF \<50%

Where it's running

  • Hospital Universitario Virgen de las Nieves
    Granada, Andalusia, Spain
    Recruiting
  • Hospital Clínico Universitario Lozano Blesa
    Zaragoza, Aragon, Spain
    Recruiting
  • Hospital Universitari i Politècnic La Fe
    Valencia, Valencia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.